by teamneuro-kinesis | Jun 10, 2010 | TImeline
A full CGCI Suite was installed at the University Hospital of La Paz in Madrid, Spain in order to begin a 20 patient human trail. Under the direction of noted cardiologist and Principal Investigator, Dr. Jose Merino who is the Director of the Arrhythmia and...
by teamneuro-kinesis | May 12, 2010 | TImeline
The first full-scale prototype of the CGCI platform is completed. The unit utilizes eight magnetic lobes, each containing a twenty-four-inch coil capable of producing a magnetic field of 1900 Gauss. The unit stands seven feet tall and has a floor weight of 20,000lbs....
by teamneuro-kinesis | Sep 1, 2009 | TImeline
The CGCI platform was granted UL Certification thereby approving the device for use in the medical field. This certification certifies that the CGCI Platform meets all the stringent electrical safety standards required for both electrical safety concerns as well as...
by teamneuro-kinesis | Dec 31, 2008 | TImeline
Additional breakthroughs in the advancement of the CGCI technology platform result in nine patents being submitted relating to the apparatus and method for controlling catheter positioning and orientation, the magnetic linear actuator for deployable catheter tools,...
by teamneuro-kinesis | Dec 11, 2007 | TImeline
An additional nine patients over the course of the preceding year relating to CGCI’s apparatus, method, and system for radar-assistance as well as the first patents for what would become the Optical Catheter are filed. This patent represented the first application for...
by teamneuro-kinesis | Nov 11, 2007 | TImeline
The first large animal study utilizing the CGCI-1 begins at Cedars Sinai Hospital in Los Angeles, California. The study consisted of 15 subjects undergoing a simulated AFib procedure to show the ability of CGCI to move a catheter to an identified target site, remember...
